A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.
Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF.
Duffy AG, et al. Among authors: turkbey b.
United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587.
United European Gastroenterol J. 2015.
PMID: 26535124
Free PMC article.